<\/p>\n
AA’n\u0131n “Gen\u00e7 Mucitler” isimli dosyas\u0131n\u0131n d\u00f6rd\u00fcnc\u00fc b\u00f6l\u00fcm\u00fcnde T\u00fcrk Patent ve Marka Kurumunca (T\u00dcRKPATENT) t\u0131p alan\u0131nda patent verilen “L-FABP Proteininin \u0130mpedimetrik Olarak \u00d6l\u00e7\u00fcm\u00fcn\u00fc Sa\u011flayan Biyosens\u00f6r” projesinin detaylar\u0131 ele al\u0131nd\u0131.<\/p>\n
T\u00dcRKPATENT taraf\u0131ndan d\u00fczenlenen “Patentle T\u00fcrkiye-3. \u00dcniversiteler Patent Yar\u0131\u015fmas\u0131”nda hocalar\u0131 Ceyhan Ceran Serdar ve Zihni Onur Uygun ile birinci olan Tutar, b\u00f6brek hastal\u0131klar\u0131n\u0131n erken te\u015fhisini sa\u011flayan bulu\u015flar\u0131n\u0131n patentini ald\u0131.<\/p>\n
AA muhabirine de\u011ferlendirmelerde bulunan Tutar, \u00fcniversite 1. s\u0131n\u0131ftayken dan\u0131\u015fman hocas\u0131n\u0131n “t\u0131p literat\u00fcr\u00fcndeki eksikleri ke\u015ffetme” \u00f6nerisi \u00fczerine ara\u015ft\u0131rmalar yapt\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n
Tutar, daha sonra t\u0131p, tar\u0131m ve hayvanc\u0131l\u0131k alan\u0131nda \u015feker gibi baz\u0131 hastal\u0131klar\u0131n erken te\u015fhisinde kullan\u0131lan “biyosens\u00f6rler” alan\u0131nda bir literat\u00fcr \u00e7al\u0131\u015fmas\u0131 ba\u015flatt\u0131klar\u0131n\u0131 dile getirdi.<\/p>\n
Ara\u015ft\u0131rmalar\u0131 s\u0131ras\u0131nda D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fcn\u00fcn yay\u0131mlad\u0131\u011f\u0131 makalelerden b\u00f6brek hastal\u0131klar\u0131n\u0131n “d\u00fcnyada en \u00e7ok \u00f6l\u00fcme neden olan 10 hastal\u0131ktan biri” oldu\u011funu \u00f6\u011frendi\u011fini belirten Tutar, \u015f\u00f6yle devam etti:<\/p>\n
“Bu sebeple b\u00f6brek hastal\u0131klar\u0131n\u0131n erken te\u015fhisi i\u00e7in bu alanda biyosens\u00f6r kullan\u0131m\u0131n\u0131 sa\u011flayacak projeler \u00fczerinde \u00e7al\u0131\u015fmaya ba\u015flad\u0131m. \u015eu anda kullan\u0131lan mevcut biyobelirte\u00e7lerden birinin literat\u00fcre yeni giren L-FABP proteini oldu\u011funu g\u00f6rd\u00fck. Bunun hakk\u0131nda yaz\u0131lan makaleleri okuduk. Bu proteinin halihaz\u0131rda biyosens\u00f6r\u00fc olmad\u0131\u011f\u0131n\u0131 g\u00f6rd\u00fck. ‘Madem bu L-FABP biyobelirteci b\u00f6brek hastal\u0131klar\u0131na erken te\u015fhis koyabiliyor ve hen\u00fcz bir biyosens\u00f6r\u00fc yok, biz de bu alana y\u00f6neliriz.’ dedik. Okulumuzun Teknoloji Transfer Ofisi, ‘Bu daha \u00f6nce bulunmad\u0131\u011f\u0131 i\u00e7in fikri m\u00fclkiyet haklar\u0131na girer. Patent ba\u015fvurusu yapman\u0131z gerekir.’ dedi. Biz de bu sayede yar\u0131\u015fmaya ba\u015fvurduk. Sonu\u00e7ta hem patent ald\u0131k hem de \u00fcniversiteler aras\u0131nda birinci olduk.”<\/p>\n
Tutar, patentin hayata ge\u00e7mesi i\u00e7in ad\u0131m ad\u0131m ilerlediklerini, bunun bir\u00e7ok a\u015famas\u0131 oldu\u011funu s\u00f6yledi.<\/p>\n
\u00c7al\u0131\u015fmalar\u0131n\u0131n \u015fimdiden sekt\u00f6rden b\u00fcy\u00fck ilgi g\u00f6rd\u00fc\u011f\u00fcn\u00fc dile getiren Tutar, \u015funlar\u0131 kaydetti:<\/p>\n
“Biz \u015fu anda prosed\u00fcrleri takip ediyoruz. Fikrimizi gelecek y\u0131llarda hayata ge\u00e7irmeyi umuyoruz. B\u00f6ylece T\u00fcrkiye’deki sa\u011fl\u0131k kurulu\u015flar\u0131nda kolayca uygulanabilecek, b\u00f6brek hastal\u0131klar\u0131n\u0131n erken te\u015fhisini sa\u011flayacak bir biyosens\u00f6r \u00fcretmek istiyoruz. Bizim projemizle insanlar, hastaneye gitmelerine gerek kalmadan, ev veya sa\u011fl\u0131k kurulu\u015flar\u0131nda bu biyosens\u00f6rlerle kendileri b\u00f6brek fonksiyon durumlar\u0131n\u0131 h\u0131zl\u0131 \u015fekilde \u00f6l\u00e7ebilecekler.”<\/p>\n